Develops innovative sleep technology products and wellness solutions. Integrates science-backed methods to enhance sleep quality and overall well-being. Now — the numbers.
This is an established company with proven profits.
Average growth of 11% a year over the last 4 years. Every year shown ended in profit.
The gap is $8.1B. In times of high interest rates, a gap like that can squeeze a company.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly above the class average — a step short of the very top.
Clearly below the class average.
Clearly below the class average.
Clearly above the class average — a step short of the very top.
Clearly below the class average.
Valuation: The stock trades at a price that looks expensive next to its earnings; that can cap future returns.
Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.
The stock trades 32% below its peak. The market has trimmed its expectations for the company.
Over the last 4 years, sales grew about 11% a year on average.
It met or beat analyst expectations in 8 of the last 8 quarters — consistency is a promise kept.
Over the last 12 months, company executives reported 77 buys and 71 sells. Management buying with its own money is usually read as a good sign.
The company’s market value is 37 times its annual profit. Even a small disappointment could hit the price hard.
Today’s price already includes part of tomorrow’s optimism. Report-card grade: 33/100.
The balance sheet offers little cushion against a rough stretch. Report-card grade: 37/100.
On our five-subject report card, SGI sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: SGI is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.
Analysts’ average target sits above today’s price, yet the valuation grade (33/100) says the stock isn’t cheap.
Not covered, because the filings we hold do not carry it: the revenue breakdown.